Evidence map›Paper›PMID 31775658›Full record

Observational studyBMC gastroenterology2019

A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels.

Pengzi Zhang, Wenhuan Feng, Xuehui Chu, Xitai Sun, Dalong Zhu, Yan Bi

Erratum issuedOpen access · goldAbstract readObservational StudyValidation Study
In one paragraph

Observational study in BMC gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2023
    Article
  4. Article
  5. The beneficial metabolic actions of prolactin.Frontiers in endocrinology · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pengzi ZhangDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, No 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Wenhuan FengDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, No 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Xuehui ChuDepartment of General Surgery, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China.
Xitai SunDepartment of General Surgery, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China.
Dalong ZhuDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, No 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Yan BiDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, No 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China. biyan@nju.edu.cn.
Nanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundsTo investigate the value of prolactin (PRL) in diagnosing non-alcoholic fatty liver disease (NAFLD).

methodsMetabolic parameters and serum PRL levels were measured in 452 males and 421 females, who were randomized to the estimation or the validation group as a 1:1 ratio. Hepatic steatosis was diagnosed via abdominal ultrasound. Variables that significantly associated with NAFLD in univariate analysis were included in multiple logistic regression. We used the receiver operator characteristic (ROC) curves to test the model performance. Besides, 147 patients underwent metabolic and liver biopsy were analyzed to validate the diagnostic value of this model.

resultsBody mass index, alanine aminotransferase, prolactin, high density lipoprotein cholesterol and HbA1c were included into models. In males, the area under ROC curve (AUC) was 0.86 (95%CI: 0.82-0.91) for the validation group. With two cut-off points (- 0.79 and 1.71), the sensitivity and specificity for predicting NALFD was 95.2 and 91.1% in the validation group, respectively. In females, the AUC was 0.82 (95%CI: 0.76-0.88) for the validation group. With two cut-off points (- 0.68 and 2.16), the sensitivity and specificity for predicting NALFD was 97.1 and 91.4% in the validation group, respectively. In subjects with liver pathology, the AUC was higher than that of fatty liver index. A positive correlation between the scores of the model and the severities of NAFLD was observed. Importantly, we demonstrated a potential value of this model in predicting nonalcoholic steatohepatitis.

conclusionWe established a mathematic model that can conveniently and effectively diagnose the existence and severities of NAFLD.

Indexed as

Models, TheoreticalAdultAlanine TransaminaseBiomarkersBiopsyBody Mass IndexCase-Control StudiesFemaleGlycated HemoglobinHumansLipoproteins, HDLLiverMaleMiddle AgedNon-alcoholic Fatty Liver DiseaseProlactinAlanine TransaminaseBiomarkersGlycated Hemoglobinhemoglobin A1c protein, humanLipoproteins, HDLProlactinDiagnostic modelNonalcoholic fatty liver diseaseProlactin

Identifiers

PMID31775658
PMCPMC6882057
OpenAlexW2990492312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.